For a better user experience please update your browser or use Chrome or Firefox browser.
Utilities
Publication detail
HomeSicherung künftiger COVID-19-Impfstoffe für Europa
There is a newer edition of this publication.
Publication metadata
Impfstoffe sind unsere beste Chance, der COVID-19-pandemie ein Ende zu setzen. Die Europäische Kommission legt derzeit eines der größten Portfolios unterschiedlicher Impfstoffe an, die sicher, wirksam und erschwinglich sind.
- Published:
- Corporate author(s): Directorate-General for Communication (European Commission)
- Themes: Public health
- Subject: clinical trial , coronavirus disease , epidemic , medical research , public awareness campaign , public health , safety standard , vaccination , vaccine
|
PDF
|
|||
| ISSN | ISBN 978-92-76-28517-5 | DOI 10.2775/807143 | Catalogue number NA-03-21-005-DE-N |
|
Web version
View the HTML version
|
|||
| ISSN | ISBN 978-92-76-28574-8 | DOI 10.2775/241 | Catalogue number NA-03-21-005-DE-Q |
|
Paper
|
|||
| ISSN | ISBN 978-92-76-28559-5 | DOI 10.2775/845 | Catalogue number NA-03-21-005-DE-C |
- Released on EU publications website:
This publication is available for download in web format (PDF) and in print-quality format (PDF/X). For more information on how to print your own copy of EU publications, please refer to our FAQ section.
Document viewer
Note:
The publication cannot be displayed in the document viewer. Open web version
You may access it from: Download and languages